OCUL icon

Ocular Therapeutix
OCUL

Overview Fund Activity

149 hedge funds and large institutions have $1.04B invested in Ocular Therapeutix in 2020 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+41
Holders Change %
+37.96%
% of All Funds
2.64%
Holding in Top 10
10
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+100%
% of All Funds
0.18%
New
54
Increased
48
Reduced
35
Closed
13
Calls
$12.3M
Puts
$4.96M
Net Calls
+$7.31M
Net Calls Change
+$7.48M

Top Buyers

1
BlackRock
BlackRock
New York
+$29.6M
2
EA
Emerald Advisers
Pennsylvania
+$24.6M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$23.2M
4
Victory Capital Management
Victory Capital Management
Texas
+$22.5M
5
GPP
Great Point Partners
Connecticut
+$17.7M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$40.9M
2
IC
Ikarian Capital
Texas
-$21.4M
3
VVM
Versant Venture Management
California
-$15.5M
4
ECM
Endurant Capital Management
California
-$11.3M
5
DAM
Deltec Asset Management
New York
-$6.28M
Name Holding Trade Value Shares
Change 		Shares
Change %
TI
151
Trexquant Investment
Connecticut
– -$250K -32,791 Closed
OMC
152
Old Mission Capital
Illinois
– -$184K -24,200 Closed
VF
153
Virtu Financial
New York
– -$148K -19,459 Closed
JF
154
Jump Financial
Illinois
– -$123K -16,200 Closed
JCM
155
JS Capital Management
New York
– -$90K -11,800 Closed
HF
156
HRT Financial
New York
– -$84K -11,165 Closed
VFA
157
Valeo Financial Advisors
Indiana
– -$23K -3,000 Closed
PHK
158
Point72 Hong Kong
Hong Kong
– -$3K -376 Closed
PCM
159
Prelude Capital Management
New York
– -$2K -200 Closed
3 4 5 6
7